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Abstract—Through the use of semi structured interviews with
medical device software organizations it emerged that medical
device software organizations are experiencing difficulties when
following plan driven Software Development Life Cycles (SDLC),
particularly in the area of requirements management. To attempt
to resolve these issues an examination of the non-regulated
industry was performed to determine if lessons learned there
could be applied to the development of medical device software.
This examination revealed that agile methods are being widely
adopted in the non-regulated software industry. To learn if agile
methods could be adopted when developing medical device
software a mapping study was performed which looked for
instances of where agile methods have been used in regulated
industries and where they have been adopted, to what success.
This mapping study revealed that incorporating agile practices
with the existing plan driven SDLC is the most favourable choice
for medical device software organizations. This research aims to
develop a SDLC which has a foundation of a plan driven SDLC
which incorporates agile practices which can be followed when
developing regulatory compliant software.
Index Terms—Medical Device Software, Safety Critical, VModel, Agile, FDA, AV-Model

I.

INTRODUCTION

Medical device software, as with most other safety critical
software, must be developed in accordance with the regulatory
requirements of the region into which the software is being
marketed. Regulatory requirements are in place to ensure the
safe and reliable functioning of the software. For the purpose
of this paper, we will be focusing on developing medical
device software which must be compliant with the Federal
Drugs Administration (FDA) regulations for use in the United
Sates (US).
Medical device software developers typically develop
software in accordance with a plan driven sequential Software
Development Lifecycle (SDLC), such as the V-Model [1], as it
appears to be the “best fit” with regulatory requirements [2].
To gain a deeper insight into the challenges experienced when
developing medical device software we performed semistructured interviews with 7 medical device software
organizations. An expected finding of the interviews was that
regulatory controls introduce a large amount of overhead when
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developing medical device software. Each of the organizations
identified that the process of introducing a change once
development has begun results in revisiting stages of
development and therefore increases costs. Based upon the
findings of the interviews we began to look at software
development methods that are better suited to accommodating
requirements changes
In the non-regulated software development industry, there
is a move away from plan driven SDLC’s towards agile
software development methodologies and practices [3]. Agile
methodologies and practices appear to offer a “silver bullet” to
problems associated with following a plan driven SDLC such
as being inflexible and unable to accommodate changes [4,
p.41]. Evidence exists which reports significant benefits being
gained within the non-regulated software development
industry from utilising agile practices, such as reduced costs,
reduced time to market and increased quality [5]. Despite this,
the rate of adoption of agile practices amongst medical device
software development organizations is low. There is no
conclusive reason for this; however, a number of reasons have
been cited. One such reason is that agile practices appear to be
contradictory to regulatory requirements [6]. For example,
medical device software organizations are required to submit
extensive documentation to prove their device is safe for use
in order to achieve regulatory approval, yet one of the four
values of the agile manifesto states, “working software over
comprehensive documentation” [7]. This would appear to
suggest that following agile methods would not produce the
necessary documentation required when seeking regulatory
approval. Even though agile software development practices
are often perceived to be contradictory to regulatory
requirements, case studies have emerged from medical device
software development organizations which have successfully
adopted agile practices and received regulatory approval. For
example, Abbott Diagnostics integrated agile practices with
their plan driven SDLC on a development project and reported
a cost saving of between 35% and 50% when compared to
following a plan driven software development lifecycle [8].
Lightweight methods such as the Crystal Family of
methodologies do appear to offer guidance for the
development of safety critical software. Crystal methods place
the agile values secondary to the primary focus of the software

which can be: People, Interactions, Community, Skills, Talents
and Communications. The Crystal methods use a coloured
weighting scheme based upon criticality and objectives to
determine which “colour” to use i.e. Crystal Clear, Crystal
Orange etc. [9]. This would appear to be of value to the
development of medical device software; however, the crystal
methods do not take into account regulatory requirements and
therefore can be difficult to wholly follow when developing
regulatory compliant software.
This paper attempts to answer the following research
questions:
1) Can agile practices be used to develop medical device
software?
2) If agile practices can be used to develop medical device
software, how must be incorporated with the existing lifecycle
in order to meet regulatory requirements?
To answer these research questions, semi structured
interviews and a mapping study were performed. This paper
outlines the interviews conducted with medical device
software organizations as part of this research into the field of
medical device software development. In our discussion on
the SDLC which medical device software organizations
currently adopt (Section II-C), we note that prior research has
found that the V-Model is the most widely used [1]. Following
this, we carried out a Mapping Study into the use of agile
software development in medical device software
development industries and propose the Agile V-Model (AVModel) as a SDLC for use in the medical device industry. It
aims to provide medical device software developers with the
structure to follow a plan driven approach whilst reaping the
benefits of utilising agile practices.
II.

MEDICAL DEVICE SOFTWARE DEVELOPMENT

A. Software Development Techniques
Medical devices marketed for use within the USA must
conform to the FDA CFR 21 Part 820 QSR [10]. Part 820.30
Subpart C “Design Controls” is specifically targeted at
medical device software developers. The design controls cover
the following areas: Design and Development Planning,
Design Input, Design Output, Design Review, Design
Verification, Design Transfer, Design Changes and Design
History File.
Whilst these stages appear to follow each other
sequentially, the FDA does not dictate the use of a sequential
SDLC such as the Waterfall Model to complete these stages.
The GPSV states “this guidance does not recommend any
specific life cycle model or any specific technique or method”.
B. Use of the V-Model in the Medical Device Industry
Despite not dictating a SDLC to follow, medical device
software development organizations typically follow the VModel [11]. It was first presented in 1991 at the NCOSE
symposium [12] and is a variation on a SDLC which Royce
presented which later became known as the Waterfall Model
[13]. The V-Model identifies that there are different types of
testing such as modular testing and integration testing [14].
The V-Model shows the relationship between the two sides of

the development process. This relationship is used to
determine whether the stage has been completed successfully.
If a problem occurs during the verification or validation of any
one stage, then the opposite stage on the “V” must be revisited
and if necessary reiterated [15]. Essentially, the testing of a
product is planned in parallel with the corresponding phase of
development. This method of developing software eases the
process of achieving traceability. The FDA mandates that
traceability be an integral part of a development process [16].
Therefore the V-Model is perceived to be the “best fit” with
the regulatory requirements. While it may be the best fit, in
practice the V-Model presents the same problems that are
associated with utilizing any sequential plan driven SDLC.
Royce, who presented the Waterfall model stated there are
inherent problems associated with following a sequential
lifecycle [13]. For example, as requirements are fixed at such
an early stage, it can be very difficult to introduce a change in
requirements once the project is underway. Also, it can be
very difficult to capture all of the requirements at such an early
stage of a project [4]. In addition to this, any changes
introduced once a project is underway can create cost and
budget overruns [17].
C. AAMI TIR 45:2012
In October 2012, the Association for the Advancement of
Medical Instrumentation (AAMI) released a Technical
Information Report (TIR) entitled TIR 45:2012--Guidance on
the use of agile practices in the development of medical device
software [18]. The committee which developed the TIR
consisted of industry experts and FDA staff. The AAMI
recognised the shift in the non-regulated software development
industry towards more agile practices and the evidence
presented from successful adoption of agile practices in
medical device software development organizations. However,
they identified that the available information which details the
use of agile practices in the development of medical device
software was hard to understand and the objective of the TIR
is to provide clear guidance on which agile practices are suited
to the development of medical device software. The TIR also
provides recommendations for complying with international
standards and FDA guidance documents when using agile
practices to develop medical device software. However, this
document is at a high level and only addresses the use of a
limited number of agile practices when developing software in
accordance with IEC 62304 which in itself does not provide
guidance for the development of standalone software [19].
III.

AGILE IN MEDICAL DEVICE SOFTWARE DEVELOPMENT

Research to date has revealed that the non-regulated software
development industry is benefiting from moving towards more
agile processes [8]. However, the medical device software
development industry has not reaped the same benefits. This
research aims to establish why these successes have not been
replicated to great extent. This research is being performed
following a Pragmatic Approach and in collaboration with
medical device software organizations. As this research aims
to overcome the challenges faced by these organisations it is
therefore prudent to learn first-hand what the challenges

experienced are. This interviews detailed do not aim to seek
statistical generalisation, but rather to seek theoretical
generalisation [20].
A. Semi-Structured Interviews
To gain a deeper insight into the challenges faced by
medical device software development organizations SemiStructured interviews were performed in accordance with
Wengraf [21]. The interviews performed are known as SemiStructured Depth Interviews (SSDI). SSDI are broken into two
classifications, Heavily Structured Depth Interviews and
Lightly Structured Depth Interviews. The degree of the
structuring is determined by the degree to which the questions
and interventions are pre-prepared by the researcher. In
accordance with Wengraf the interviews were broken in to
four elements: Research Purposes (RP), Central Research
Questions (CRP), Theory Questions (TQ) and Interview
Intervention (II)\Interview Questions (IQ).
The RP is the motivation behind the research being
conducted. For this research, the RP is to gain a deeper insight
into difficulties experienced when developing medical device
software. The CRQ is the primary question(s) to which
answers are being sought as a result of the interview being
conducted. The TQ are high level questions. These questions
are not asked directly to the interview participant. TQ are used
to formulate the actual questions that will be asked of the
participant. II/IQ is what is actually asked of the participant
during the interview. The information gleaned from the
responses is compiled to answer the TQ which in turn answer
the CRQ which ultimately supports the RP.
The results of the interviews were analyzed in accordance
with Wengraf’s Interview Material to Answers to Theory
Questions to an Answer to the Central Research Question (IMATQ-ACRQ) model [21]. Whilst the CRQ > TQ > IQ/II
model utilizes a top down approach, the IM-ATQ-ACRQ
model utilizes a bottom up approach to determine the answer
to the central research question. This method was used as it
complimented the method employed for the creation of the
interview questions i.e. RP > CRQ > TQ > IQ/II. The results
were also analyzed in accordance with Miles and Huberman’s
[22] method of analyzing qualitative data i.e. Data Reduction,
Data Display and Conclusion Drawing & Verification.
Each of the organizations involved in the interviews
identified that a major problem they experience is
accommodating changes once development has begun. To
accommodate changes a number of stages may need to be
revisited, having a knock on effect of increasing rework and
therefore increasing cost. When asked in the interviews how to
resolve the problems associated with changing requirements a
number of responses were given. One organization suggested
the establishment of an incubation period prior to the
requirements analysis stage. This incubation period would
allow the customer time to consider all potential features they
wished to include in the software and ideally removing the
need for a change to be implemented once the project has
begun. Another organization suggested placing greater
emphasis on up-front planning and again making sure all of the
necessary requirements were captured. One organization

suggested “placing manners on the customer” and preventing
them from introducing a change once development has begun.
Each of these suggestions has their own merit, however
these are proactive steps, none of the organizations were able
to suggest a reactive response to when a requirements change
was unavoidable. Current plan driven SDLCs are rigid and
therefore have difficulty accommodating a change. Typically,
when a change is introduced a number of stages need to be
revisited to accommodate the change. This can require a lot of
rework therefore increasing cost and development time. As a
result a software development method which can
accommodate changes once development has begun could
bring benefit to medical device software organizations.
B. Mapping Study
While the interviews performed identified the challenges
faced by medical device software development organisations,
they did not answer the question as to how these problems can
be overcome. As discussed agile methods would appear to
solve the problems mentioned; however this needed to be
confirmed. To understand why the medical device software
development industry has not benefited from adopting agile
practices this paper focuses on the following research
questions.
To answer these questions, a Mapping Study was
performed. This Mapping Study was conducted in accordance
with guidelines from Petersen et al. [23]. From an overall
perspective, this process involved three main steps: 1.
planning the review, 2. conducting the review and 3. reporting
the review.
By approaching the review in such a systematic manner
and demonstrating the rigor applied to each step, we build a
higher level of confidence in our conclusions. We developed a
protocol containing a full breakdown of the research approach.
The Mapping Study quickly showed there to be limited
published material in this specific area. In order to progress
our investigation, we widened our review to cover regulated
safety-critical software development in general. Due to
similarities in the domains, lessons learned from within other
regulated safety critical industries, such as Avionics and
Automotive, software development can potentially be applied
to the development of medical device software. We
specifically included the following priori assumption to make
any bias clearly identifiable:
TABLE 1 LITERATURE SOURCES

SOURCE
ACM
Compendex
IEEE
INSPEC
Science
Direct
Web of
Science
Misc.

URL
http://portal.acm.org/portal.cfm
http://www.engineeringvillage2.org
http://ieeexplore.ieee.org/Xplore
http://www.theiet.org/inspec
http://www.sciencedirect.com
http://apps.isiknowledge.com
Book Sections, Thesis, Industry Reports,
Websites

TABLE 2 QUESTIONS USED TO SOLICIT QUALITY OF PAPER

Does the study predominantly relate to software
development with a safety critical regulated setting?
Which particular agile methodology does it look at in
depth?
Does it report on real-life case studies where an agile
methodology was used?
Does the study find in favour of the applicability of agile
software development methodologies within a safetycritical, regulated setting?
What ‘flavour’ of agile does the study promote?
- Agile (the practices of a single agile methodology)
- Agile – Agile (a combination of different agile
methodologies)
- Agile – Planned (A combination of agile and traditional
methodologies)
- None (it does not recommend agile methodologies)
Some practices/aspects of agile software development do not
adequately support all the requirements of the regulations for
safety-critical software development, such as those laid down
by the US regulatory bodies.
The main tasks described in our protocol are: identifying data
sources, building search strings, performing pilot search,
adjusting search criteria, exporting results for citation
management, applying inclusion/exclusion criteria, quality
assessment, data extraction and data synthesis. While we
found this a very positive approach in terms of providing a
clear and unambiguous path through the literature, other
important contributions were available from industry sources
such as non-academic books, reports and other online
resources. Our opinion is that this grey literature assists in
addressing publication bias. Therefore, it was included in our
study.
C. Search Sources and Strings
Taking the Mapping Study guidelines as a starting point
and looking at other published Mapping Studies and
Systematic Literature Reviews (SLR) [24-27], we used the
electronic sources noted in Table 1. An important lesson in the
practice of searching electronic databases, is that each
database search engine is different as highlighted by Brereton
et al. [28].
The specific search strings were formed following the
Population, Intervention, Comparison, Outcomes and Context
(PICOC) criteria suggested by Petticrew and Roberts [29]. The
generic query we used can be written as follows:
“any document containing the phrase ‘medical device’ or
‘embedded software’ or the word stem ‘regulat’ AND any of
the following phrases (‘software development’, ‘software
process’, ‘software life-cycle’, ‘manufacturing software’) AND
containing any of the following words/phrases (‘agile’,
‘scrum’, ‘XP’, ‘extreme programming’, ‘crystal’, ‘lean’.).
D. Inclusion and Exclusion Criteria
The inclusion criteria were:
- Peer Reviewed Research Papers;

- Grey Literature from experienced practitioners;
- Relevant to safety-critical software development;
- Focus on agile practices.
The exclusion criteria included:
- Non-English language;
- Content too general (for example a high level review
of agile practices);
- Duplicated work;
- Off Topic (Does not concentrate on expected subject
matter)
E. Quality Attributes
As described by Petersen et al. [23], an integral part of a
Mapping Study is to assess the quality of the primary studies.
This aids in determining the relevant importance of a study by
capturing, for example:
- The possible effects of bias;
- The importance of a study in the body of literature;
- The relevance to your particular research questions(s).
In order to determine the value of each paper, a series of
questions were asked of each one (Table 2) and the answer
recorded on the data extraction sheet. Following this, we
added an overall rating [1-poor to 5-excellent] to each entry.
This step had particular importance as many of the papers
were not empirically based. The average overall rating was
3.46. Of the 26 papers identified, 2 was the lowest rating
given.
F. Data Extraction
Following the technique used by Dyba and Dingsor [30]
for citation management, the results of the searches were
exported.
The
publications
underwent
an
initial
inclusion/exclusion analysis. This was carried out by the
primary reviewer and validation performed by the secondary
reviewers.
A two-step approach to the inclusion/exclusion was carried
out. First, papers were excluded on the basis of their title and
abstract. All remaining papers were then read in full and
irrelevant papers were excluded. The remaining entries formed
the basis of the review. The relevant data was extracted into
Microsoft Excel Spread sheet (data extraction template),
where subsequent information, such as inclusion/exclusion
justification, quality attributes and a short note on the
limitations of each publication, were recorded. From an initial
count of 193 results, the data set was reduced to 64 in the first
TABLE 3 SEARCH RESULTS SUMMARY
nd

st

SOURCE

Count

1 Review

ACM
Compendex
IEEE
INSPEC
Science Direct
Web of Science
Misc.
Total

72
35
20
15
29
5
17
193

18
11
11
5
4
0
15
64

2
Review
6
6
7
2
0
0
5
26

review, and then to 26 in the second review. The 26 results
spanned the years 2002-2012. Of experience reports published
at international conferences (50%), only 6 were classified as
empirical research papers – 5 case studies and 2 surveys. This
is indicative of the lack of empirical research in this specific
field.
G. Data Synthesis
While the Mapping Study detailed here looked at regulated
embedded software development in general, we have a special
interest in medical device software development. The
Mapping Study found that 11 papers (42%) report from a
medical device perspective. This acts as evidence that agile
practices can be followed when developing medical device
software. All of the organizations which reported using agile
practices to develop medical device software, highlighted that
using them had a positive impact within their development
project. The agile methodologies which appeared most
throughout the literature were XP and Scrum.
One of the areas we were interested in investigating was
the ‘flavour’ of agile being adopted/trialled in this domain.
The Mapping Study determined whether full standalone agile
methodologies (Agile), a combination of different agile
methodologies (Agile-Agile), or utilising agile in conjunction
with traditional plan driven development techniques (AgilePlanned) was being favoured. The results show that almost
46% of the papers reported on the adoption or trials of AgilePlanned usage, with 19% adopting Agile, a further 19%
adopting Agile-Agile and the remaining 16% reported no
preference. Therefore, our Mapping Study provides evidence
that a hybrid model incorporating agile with plan driven
methodologies is the most favourable option when developing
medical device software.
IV.

TAILORED SOFTWARE DEVELOPMENT LIFECYCLE

As shown in the Mapping Study, there is still a limited
amount of publicly available information detailing where
medical device organizations have utilised agile practices.
Despite this, there is evidence to suggest [8, 31] that medical
device software development projects can benefit from
embracing agile practices. Whilst the Mapping Study revealed
that agile practices can be used in the development of medical
device software, it also revealed that a combination of Agile
and Planned appears to be more suited to the development of
medical device software. Through the Mapping Study, it
emerged that there is currently no single SDLC which medical
device software developers can follow when developing
medical device software which combines agile and plan driven
techniques. Instead, organizations employing agile are
tailoring their existing lifecycles to incorporate agile practices.
This method may be suited to large organizations with
multiple projects that can trial agile practices in a project to
determine whether they appropriate. Smaller medical device
software developers may only be working on a single project
at a time and cannot risk trialling agile on their only project.
The hybrid SDLC proposed in this paper aims to provide
medical device software development organizations,
regardless of size or maturity, guidance on the development of

safe and reliable medical device software which is regulatory
compliant, whilst reaping the benefits associated with utilising
agile practices.
A. Development of Agile V-Model
The process of developing the Agile V-Model is broken
into clear distinct phases:
1. Selection of foundation plan driven SDLC;
2. Preparing for inclusion of agile practices into plan
driven SDLC;
3. Identification of applicable agile practices to the
development of medical device software.
1) Selection of foundation plan driven SDLC: When
selecting the foundation of the hybrid SDLC, a number of plan
driven SDLCs were examined. The conclusion was made that
the V-Model is the most appropriate model on which to build
the hybrid SDLC. The reasons for choosing the V-Model are:
• Medical device software organizations typically follow the
V-Model to develop medical device software. As a result,
they are already familiar with the structure and phases of
the V-Model and would be more willing to adopt a hybrid
model based upon a SDLC with which they are familiar.
• Medical device software organizations may have received
regulatory approval to follow the V-Model when
developing medical device software. If these organizations
move to a completely different SDLC, they may need to
re-apply for regulatory approval for the new SDLC. This
may be a barrier as organizations could be reluctant to
undergo regulatory approval again.
• Whilst none of the regulatory requirements or development
standards mandate the use of the V-Model, it appears to be
the best fit with regulatory requirements, as it guides
organizations through the process of producing the
necessary deliverables required to achieve regulatory
conformance.
2) Preparing for Inclusion of Agile practices into plan
driven SDLC: Each of the agile methodologies advocates
iterative software development. Each of the sequential plan
driven SDLCs suffer the problem of being rigid and inflexible
to change. With iterative techniques, changes can be
introduced to a development project without needing to revisit
a number of other stages of the SDLC. However, to
incorporate iterative techniques, the process of “Risk
Identification” needs to be added to the model. Risk
Identification involves analysing the project, dividing it into
iterations and identifying the iterations which pose the most
risk to the project. The iterations that pose the most risk are
then performed as early as possible in the project. Once risk
identification is added, each of the stages of the V-Model is
assessed to determine which stages could be performed
iteratively. As a result, all of the stages of the development
lifecycle are divided into two categories: stages that can be
performed iteratively and stages that can only be performed in
a single pass. For example, the FDA requires the device

manufacturers to submit high level requirements prior to
beginning development. Therefore, this can only be done
once. Also, the process of achieving regulatory approval can
only be sought when a device is completed and the acceptance
tests have all passed. Therefore, this can only be completed
once. However, other stages such including “Software
Architecture Design” and “Unit Implementation” can be
performed iteratively.
3) Identification of applicable agile practices to the
development of medical device software; To identify agile
practices applicable to the development of medical device
software, each of the agile methodologies - Scrum, XP,
DSDM and Crystal clear - were examined. Based upon this
examination, 59 agile practices were identified. A comparison
between these 59 practices and the appropriate regulations and
standards was performed. This comparison revealed that none
of the 59 identified practices contradict regulations or
development standards. However, despite these practices not
being contradictory to regulations or standards, their
applicability to the development of medical device software
development remains unclear. To determine the level of
applicability, based upon the findings of the Map ping Study,
13 practices were identified as being applicable to the
development of medical device software. These practices have
been selected based on the fact that they have been
successfully adopted in medical device software organisations
developing regulatory compliant software [32]. These
practices include iterative development, use cases/user stories
and test driven development. These 13 practices were then
mapped to the appropriate stage of the SDLC. A problem
associated with following a plan driven SDLC, is the emphasis
placed on up-front planning. This can result in a project
suffering if a change is introduced after development has
begun. Using iterative development, detailed requirements can
be easily revisited and if a change in requirements is made,
this change can be accommodated in an upcoming iteration.
Whilst only 13 practices have been identified to date, we
are continuing our validation on the remaining 46 practices.
On-going research will determine how many of the remaining
practices are applicable to medical device software
development and these practices will be mapped to the model
were appropriate. Some of the remaining practices to be
examined for applicability include, Continuous Improvement,
Definition of Done and Test Driven Development.
B. Hybrid Model
Figure 1 shows the AV-Model. Each of the 13 practices
identified through the Mapping Study is mapped to the
appropriate stage of development such as “On Site Customer”,
“Iterative Development”, “Use Cases / User Stories”. Whilst
practices have been mapped to specific stages, it does not
preclude the use of the practice at another stage of
development. For example, Fig. 2 shows the use of “User
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FIGURE 1 THE AV-MODEL

Stories” and “Use Cases” at the “Requirements Specification”
stage. These can also be used in the “Architectural Design”
stage. Two identified applicable practices not shown in the
model are “Collocated Teams” and “Self Organising Teams”.
These are not displayed graphically on the model as these
practices do not relate to a specific stage of the development
lifecycle. Rather, they are related to team structure.
C. Model Validation
The objective of the development of this model is to
resolve problems associated with following a plan driven
software development lifecycle, whilst reaping the benefits of
utilising agile practices. As the model is currently under
development it has not yet been fully validated. However,
there will be two stages in the process of validation: Expert
Opinion and Implementation. The development of the AV
model is an iterative one. Once a stage of validation is
complete feedback will be applied and the model will proceed
to the next stage of validation. Feedback will be obtained
through the use of a survey instrument with open ended
questions.
1) Expert Opinion: Once the model has received
validation from industry it will be distributed to experts in the
field of medical device software development. Agreement has
already been made with members of the IEC 62304 committee
and members of the TIR 45:2012 committee to provide
validation of the model. By eliciting this form of feedback the
model aims to gain acceptance in the standards community.
2) Implementation: Once the model has undergone the
Expert Opinion validation, it will be adopted by a medical
device software development organization. A medical device
software organization has agreed to implement the model once
it is completed and passed through each of the steps of
validation.
V.

RELATED WORK

In [33] research is conducted that provides information as to
how the avionics industry can benefit from adopting agile
practices. In this research, the author investigates the
regulatory constraints placed upon avionic software
developers adhering to DO-178B [34] and whether or not XP
can be used in this domain. The research revealed that XP
could not practically be used in the case study, but the author

surmises that avionics software development could benefit
from adopting agile practices. In [33] the authors provide
information as to how employing XP can be beneficial in areas
such as requirements managements and change management.
However, the authors also discuss that for XP to be a success
in such a project there are prerequisites such as early customer
involvement.
In Vanderleest and Butler [35] a mapping is performed
between Agile practices and the development practices as part
of DO-178B. This mapping demonstrates the ability to utilize
agile practices in the development of avionics software.
However, Vanderleest identifies that there has not been a large
amount of research in the area of using Agile in avionics and
calls for other researchers to establish collaboration to research
the area further.
Manhart and Schneider [36] present a case study of the
adoption of agile practices in the Daimler Chrysler software
engineering department. Within this study the organization
examined the possibility of adopting a full Agile methodology,
but found that a tailored framework suited there development
requirements. To that end, elements of agile i.e. test first
process, were integrated into a traditional process
improvement model. This research did not focus on any one
agile methodology to extract practices from, but rather took a
wider view of all of the agile practices.
This related work shows that other regulated industries are
examining the possibility of utilizing agile practices to
overcome the challenges associated with following plan driven
SDLCs. It also shows that where agile practices have been
used they have been most successful when incorporated with a
plan driven approach.
VI.

CONCLUSIONS

Through semi structured interviews it was revealed that
medical device software organizations are experiencing
difficulties when following a plan driven SDLC in areas such
as requirements management. To overcome these problems an
examination of other development techniques was performed.
This examination revealed that agile methods could potentially
overcome the challenges associated with following a plan
driven SDLC. To that end, through the conduction of a
Mapping Study, it has been shown that medical device
software development organizations can develop regulatory
compliant software whilst utilising agile practices. The
Mapping Study also revealed that, where adopting agile has
proved successful, the existing lifecycle was tailored to
accommodate agile practices rather than wholly embracing a
complete agile methodology such as Scrum or XP.
Although agile practices have been successfully adopted in
medical device software development organizations, this
success has not been replicated to a great extent. One potential
reason for this is the reluctance of medical device software
developers to move away from tried and tested techniques
such as the V-Model. An additional reason may also be that
medical device software development organizations have
already achieved regulatory approval to use their current
SDLC and, if they moved to a completely different SDLC,

they may need to submit for approval once more. The hybrid
model, being based upon the V-Model, will remove this need.
This paper proposes a hybrid SDLC known as the AVModel, which combines both agile and plan driven
development practices can follow when developing regulatory
compliant software. This SDLC has been developed to resolve
some of the problems, such as inflexibility, which medical
device software development organizations are experiencing
when following a plan driven SDLC. Whilst the development
of this model is on-going, medical device software
development organizations can benefit from the results of this
research to date and it is expected that the model will grow to
incorporate additional applicable practices. The remaining
applicable practices will be identified through collaborations
with medical device software development organizations.
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